Related Experiment Video
Updated: May 27, 2026

Laser Capture Microdissection of Mouse Embryonic Cartilage and Bone for Gene Expression Analysis
Published on: December 18, 2019
C/EBPβ and RUNX2 cooperate to degrade cartilage with MMP-13 as the target and HIF-2α as the inducer in chondrocytes
Makoto Hirata1, Fumitaka Kugimiya, Atsushi Fukai
1Sensory and Motor System Medicine, University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-8655, Japan. hiratam-tky@umin.ac.jp
Abstract:
To elucidate the molecular mechanism underlying the endochondral ossification process during the skeletal growth and osteoarthritis (OA) development, we examined the signal network around CCAAT/enhancer-binding protein-β (C/EBPβ, encoded by CEBPB), a potent regulator of this process. Computational predictions and a C/EBP motif-reporter assay identified RUNX2 as the most potent transcriptional partner of C/EBPβ in chondrocytes. C/EBPβ and RUNX2 were induced and co-localized in highly differentiated chondrocytes during the skeletal growth and OA development of mice and humans. The compound knockout of Cebpb and Runx2 in mice caused growth retardation and resistance to OA with decreases in cartilage degradation and matrix metalloproteinase-13 (Mmp-13) expression. C/EBPβ and RUNX2 cooperatively enhanced promoter activity of MMP13 through specific binding to a C/EBP-binding motif and an osteoblast-specific cis-acting element 2 motif as a protein complex. Human genetic studies failed to show the association of human CEBPB gene polymorphisms with knee OA, nor was there a genetic variation around the identified responsive region in the human MMP13 promoter. However, hypoxia-inducible factor-2α (HIF-2α), a functional and genetic regulator of knee OA through promoting endochondral ossification, was identified as a potent and functional inducer of C/EBPβ expression in chondrocytes by the CEBPB promoter assay. Hence, C/EBPβ and RUNX2, with MMP-13 as the target and HIF-2α as the inducer, control cartilage degradation. This molecular network in chondrocytes may represent a therapeutic target for OA.
Insights
CCAAT/enhancer-binding protein-β (C/EBPβ) and RUNX2 regulate cartilage degradation and osteoarthritis by targeting MMP-13. Hypoxia-inducible factor-2α (HIF-2α) induces C/EBPβ, forming a key molecular network for potential osteoarthritis therapeutics.
Area of Science:
- Molecular Biology
- Skeletal Biology
- Osteoarthritis Pathogenesis
Background:
- Endochondral ossification is crucial for skeletal growth and osteoarthritis (OA) development.
- CCAAT/enhancer-binding protein-β (C/EBPβ) is a key regulator in these processes.
- Understanding the molecular network involving C/EBPβ is essential for OA research.
Purpose of the Study:
- To elucidate the molecular mechanism of endochondral ossification and OA development.
- To identify the transcriptional partners and regulatory network of C/EBPβ in chondrocytes.
- To explore potential therapeutic targets for OA.
Main Methods:
- Computational predictions and motif-reporter assays to identify C/EBPβ partners.
- Gene knockout studies in mice (Cebpb and Runx2).
- Reporter assays (CEBPB promoter assay) and genetic studies in humans.
Main Results:
- RUNX2 identified as the primary transcriptional partner of C/EBPβ in chondrocytes.
- Compound knockout of Cebpb and Runx2 in mice led to growth retardation and OA resistance, with reduced cartilage degradation and MMP-13 expression.
- C/EBPβ and RUNX2 cooperatively regulate MMP13 promoter activity.
- Hypoxia-inducible factor-2α (HIF-2α) induces C/EBPβ expression in chondrocytes.
- Human genetic studies did not associate CEBPB polymorphisms with knee OA.
Conclusions:
- C/EBPβ and RUNX2 form a critical molecular complex that drives MMP-13 expression and cartilage degradation.
- HIF-2α acts as an upstream inducer of C/EBPβ in this pathway.
- This C/EBPβ-RUNX2-MMP-13 network, modulated by HIF-2α, represents a potential therapeutic target for osteoarthritis.
Related Concept Videos
Growth of Cartilage and Bone Tissue
Role of Matrix Metalloproteases in Degradation of ECM
A...
Hedgehog Signaling Pathway
Master Transcription Regulators
TGF - β Signaling Pathway
Bone Formation by Endochondral Ossification
